Tags

Type your tag names separated by a space and hit enter

[Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations].
Pol Merkur Lekarski. 2004 May; 16 Suppl 1:91-4.PM

Abstract

A one-year retrospective analysis of 175 cases of COPD exacerbation was conducted. A relationship was established between expenses, on the one side, age, smoking habit and pulmonary function tests results, on the other. The mean direct expenditure for hospital treatment of COPD exacerbation per person amounted to PLN 2374.9 +/- (1040.7) (PLN 1690.8 +/- 581.8 for exacerbation of mild COPD, PLN 2221.9 +/- 815.9 for exacerbation of moderate COPD and PLN 2961.4 +/- 1345.9 for exacerbation of severe COPD). A significant relationship was found between the costs of drugs and forced expiratory volume in the first second (FEV1%) and forced vital capacity (FVC%) (accordingly r = -0.19 and r = -0.26; p < or = 0.05). Smoking habit had significant influence on the costs of therapy only in men (r = 0.22; p < or = 0.05). Age did not have serious influence on the costs. The direct costs of COPD exacerbations in women were significantly higher than in men (accordingly: PLN 2723.3 +/- 1209.9 and 2206.7 +/- 906.9; p = 0.005). Pulmonary function test results, severity of disease and female sex are relevant factors influencing the direct costs of hospital treatment of COPD exacerbations.

Authors+Show Affiliations

Wojskowy Instytut Medyczny, Klinika Chorób Wewnetrznych, Pneumonologii i Alergologii CSK MON w Warszawie. krozyk@poczta.onet.plNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

pol

PubMed ID

15524028

Citation

Jahnz-Rózyk, Karina, et al. "[Retrospective Analysis of Direct Costs of Hospital Treatment of Chronic Obstructive Pulmonary Disease Exacerbations]." Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego, vol. 16 Suppl 1, 2004, pp. 91-4.
Jahnz-Rózyk K, Targowski T, From S, et al. [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations]. Pol Merkur Lekarski. 2004;16 Suppl 1:91-4.
Jahnz-Rózyk, K., Targowski, T., From, S., & Płusa, T. (2004). [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations]. Polski Merkuriusz Lekarski : Organ Polskiego Towarzystwa Lekarskiego, 16 Suppl 1, 91-4.
Jahnz-Rózyk K, et al. [Retrospective Analysis of Direct Costs of Hospital Treatment of Chronic Obstructive Pulmonary Disease Exacerbations]. Pol Merkur Lekarski. 2004;16 Suppl 1:91-4. PubMed PMID: 15524028.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Retrospective analysis of direct costs of hospital treatment of chronic obstructive pulmonary disease exacerbations]. AU - Jahnz-Rózyk,Karina, AU - Targowski,Tomasz, AU - From,Sławomir, AU - Płusa,Tadeusz, PY - 2004/11/5/pubmed PY - 2005/1/26/medline PY - 2004/11/5/entrez SP - 91 EP - 4 JF - Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego JO - Pol. Merkur. Lekarski VL - 16 Suppl 1 N2 - A one-year retrospective analysis of 175 cases of COPD exacerbation was conducted. A relationship was established between expenses, on the one side, age, smoking habit and pulmonary function tests results, on the other. The mean direct expenditure for hospital treatment of COPD exacerbation per person amounted to PLN 2374.9 +/- (1040.7) (PLN 1690.8 +/- 581.8 for exacerbation of mild COPD, PLN 2221.9 +/- 815.9 for exacerbation of moderate COPD and PLN 2961.4 +/- 1345.9 for exacerbation of severe COPD). A significant relationship was found between the costs of drugs and forced expiratory volume in the first second (FEV1%) and forced vital capacity (FVC%) (accordingly r = -0.19 and r = -0.26; p < or = 0.05). Smoking habit had significant influence on the costs of therapy only in men (r = 0.22; p < or = 0.05). Age did not have serious influence on the costs. The direct costs of COPD exacerbations in women were significantly higher than in men (accordingly: PLN 2723.3 +/- 1209.9 and 2206.7 +/- 906.9; p = 0.005). Pulmonary function test results, severity of disease and female sex are relevant factors influencing the direct costs of hospital treatment of COPD exacerbations. SN - 1426-9686 UR - https://www.unboundmedicine.com/medline/citation/15524028/[Retrospective_analysis_of_direct_costs_of_hospital_treatment_of_chronic_obstructive_pulmonary_disease_exacerbations]_ L2 - http://www.diseaseinfosearch.org/result/7979 DB - PRIME DP - Unbound Medicine ER -